{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:54:45Z","timestamp":1783436085018,"version":"3.54.6"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Flualprazolam is a designer benzodiazepine and novel psychoactive substance that is increasing in prevalence and appearing in forensic investigations. Flualprazolam was quantitatively confirmed in 197 blood samples from medicolegal death investigations and human performance cases reported between August 2019 and February 2020. Drug screening was performed using liquid chromatography\u2013time-of-flight mass spectrometry and quantitative confirmation was performed using liquid chromatography\u2013tandem mass spectrometry. A three-point standard addition protocol was implemented for quantitation in the absence of an available traditionally validated assay. In postmortem cases with quantitative results (n\u00a0=\u00a0167), the mean (\u00b1standard deviation [SD]) flualprazolam concentration was 20 (\u00b163) ng\/mL, the median concentration was 8.2\u00a0ng\/mL and the range of concentrations was 2.0\u2013620\u00a0ng\/mL. Four additional postmortem cases were reported positive (&amp;lt;2.0\u00a0ng\/mL). In drug impaired driving cases (n\u00a0=\u00a022), the mean (\u00b1SD) flualprazolam concentration was 22 (\u00b118) ng\/mL, the median concentration was 14\u00a0ng\/mL and the range of concentrations was 4.4 to 68\u00a0ng\/mL. The four remaining cases were of unknown circumstances. This report details the most extensive dataset of flualprazolam intoxication cases reported to date. There was significant overlap in concentrations of flualprazolam between postmortem and DUID cases. Flualprazolam was commonly (83% of the time) found in combination with opioids (e.g. fentanyl). Toxicologists should consider quantitative flualprazolam results in the context of case history, observations, and\/or other toxicological findings. Addition of flualprazolam to the scope of drug testing should be considered by all laboratories.<\/jats:p>","DOI":"10.1093\/jat\/bkaa070","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T03:21:10Z","timestamp":1591759270000},"page":"226-232","source":"Crossref","is-referenced-by-count":44,"title":["Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases"],"prefix":"10.1093","volume":"45","author":[{"given":"Donna M","family":"Papsun","sequence":"first","affiliation":[{"name":"NMS Labs, 200 Welsh Road, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex J","family":"Krotulski","sequence":"additional","affiliation":[{"name":"Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA 19090, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Homan","sequence":"additional","affiliation":[{"name":"NMS Labs, 200 Welsh Road, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D H","family":"Temporal","sequence":"additional","affiliation":[{"name":"NMS Labs, 200 Welsh Road, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry K","family":"Logan","sequence":"additional","affiliation":[{"name":"NMS Labs, 200 Welsh Road, Horsham, PA 19044, USA"},{"name":"Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, 2300 Stratford Ave, Willow Grove, PA 19090, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"2021031210492908100_ref1","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"Journal of Medicinal Chemistry"},{"key":"2021031210492908100_ref2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acschemneuro.5b00107","article-title":"Effects of Bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135","volume":"6","author":"Banister","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"key":"2021031210492908100_ref3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jlcr.2580230306","article-title":"Synthesis and evaluation of fluorinated derivatives of fentanyl as candidates for opiate receptor studies using positron emission tomograpry","volume":"23","author":"Hwang","year":"1986","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"key":"2021031210492908100_ref4","article-title":"6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines","author":"Hester","year":"1976"},{"key":"2021031210492908100_ref5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/jm00293a015","article-title":"6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity","volume":"14","author":"Hester","year":"1971","journal-title":"Journal of Medicinal Chemistry"},{"key":"2021031210492908100_ref6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11419-019-00501-1","article-title":"Identification of the designer benzodiazepine 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (flualprazolam) in an anesthesia robbery case","volume":"38","author":"Qian","year":"2020","journal-title":"Forensic Toxicology"},{"key":"2021031210492908100_ref7","article-title":"Svenska Narkotika Polisf\u00f6reningens Tidskrift","author":"Karlsson","year":"2018"},{"key":"2021031210492908100_ref8","author":"Drug Enforcement Administration","year":"2019"},{"key":"2021031210492908100_ref9","article-title":"Flualprazolam","author":"Krotulski","year":"2019"},{"key":"2021031210492908100_ref10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"Journal of Addiction Medicine"},{"key":"2021031210492908100_ref11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances\u2014Designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"NeuroToxicology"},{"key":"2021031210492908100_ref12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"2021031210492908100_ref13","author":"UNODC Early Warning Advisory (EWA) on New Psychoactive Substances (NPS)","year":"2019"},{"key":"2021031210492908100_ref14","author":"World Health Organization","year":"2019"},{"key":"2021031210492908100_ref15","article-title":"Emerging threat report mid year 2019","author":"Drug Enforcement Administration","year":"2019"},{"key":"2021031210492908100_ref16","article-title":"Emerging threat report third quarter 2019","author":"Drug Enforcement Administration","year":"2019"},{"key":"2021031210492908100_ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.110101","article-title":"Femoral blood concentrations of flualprazolam in 33 postmortem cases","volume":"307","author":"Kriikku","year":"2020","journal-title":"Forensic Science International"},{"key":"2021031210492908100_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa019","article-title":"Toxicokinetics and analytical toxicology of flualprazolam: Metabolic fate, isozyme mapping, human plasma concentration, and main urinary excretion products","author":"Wagmann","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa016","article-title":"Isotonitazene quantitation and metabolite discovery in authentic forensic casework","author":"Krotulski","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/ed057p703","article-title":"A systematic approach to standard addition methods in instrumental analysis","volume":"57","author":"Bader","year":"1980","journal-title":"J. Chem. Educ"},{"key":"2021031210492908100_ref21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jat\/bkv078","article-title":"Quantification of drugs in brain samples","volume":"39","author":"Reiter","year":"2015","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref22","first-page":"709","article-title":"Analysis of novel synthetic opioids U-47700, U-50488 and Furanyl fentanyl by LC\u2013MS\/MS in Postmortem casework","volume":"40","author":"Mohr","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref23","first-page":"14","article-title":"Emerging drug: Flualprazolam","volume":"43","author":"Papsun","year":"2019","journal-title":"ToxTalk\u00ae"},{"key":"2021031210492908100_ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jat\/9.5.207","article-title":"Preliminary report on the application of a high performance liquid chromatographic method for alprazolam in postmortem blood specimens","volume":"9","author":"Edinboro","year":"1985","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jat\/19.6.511","article-title":"High-performance liquid chromatography of alprazolam in postmortem blood using solid-phase extraction","volume":"19","author":"Hall","year":"1995","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jat\/21.3.218","article-title":"A fatality due to alprazolam intoxication","volume":"21","author":"Jenkins","year":"1997","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref27","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2020","edition":"12th"},{"key":"2021031210492908100_ref28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jat\/bkv122","article-title":"ELISA detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in blood using Immunalysis\u00ae benzodiazepine kit","volume":"40","author":"O\u2019Connor","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2021031210492908100_ref29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Bergstrand","year":"2017","journal-title":"Drug Testing and Analysis"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaa070\/33661897\/bkaa070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/45\/3\/226\/36581768\/bkaa070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/45\/3\/226\/36581768\/bkaa070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T10:50:13Z","timestamp":1615546213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/45\/3\/226\/5856455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2021,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaa070","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,6,12]]}}}